A New Gnotobiotic Pig Model of P Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines. Viruses. 2022; 14..
The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa. Viruses. 2022; 14..
Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors. FEBS Open Bio. 2022; 12:1489-1497..
A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. Pharmaceutics. 2022; 14..
Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses. Journal of Virology. 2022; 96..
Quantitative norovirus viral load is not affected by home storage of stool. Transplant Infectious Disease. 2022; 24..
Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research. 2022; 15:4181-4190..
Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens. 2021; 10..
Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?. Emerging Microbes and Infections. 2021; 10:1191-1199..
Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118..
Prevalence and Evolution of Noroviruses between 1966 and 2019, Implications for Vaccine Design. Pathogens. 2021; 10..
Characterization of Functional Components in Bovine Colostrum That Inhibit Norovirus Capsid Protruding Domains Interacting with HBGA Ligands. Pathogens. 2021; 10..
Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study. Human Vaccines and Immunotherapeutics. 2021; 17:1803-1810..
Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine. Vaccine. 2021; 39:263-271..
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses. Viruses. 2021; 13..
Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China. Epidemiology and Infection. 2020; 148..
Histo-blood group antigens as divergent factors of groups A and C rotaviruses circulating in humans and different animal species. Emerging Microbes and Infections. 2020; 9:1609-1617..
Epidemiology and HBGA-susceptibility investigation of a G9P rotavirus outbreak in a school in Lechang, China. Archives of Virology. 2020; 165:1311-1320..
Structural Basis of Glycan Recognition in Globally Predominant Human P Rotavirus. Virologica Sinica. 2020; 35:156-170..
Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens. PLoS Pathogens. 2020; 16..
Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs. Vaccines. 2019; 7..
2019; 14:303-309.. Pathogenesis and diagnosis of norovirus.
Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development. Pharmaceutics. 2019; 11..
GII.13/21 Noroviruses Recognize Glycans with a Terminal β-Galactose via an Unconventional Glycan Binding Site. Journal of Virology. 2019; 93..
Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice. Vaccine. 2019; 37:4103-4110..
Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths. Journal of Virology. 2019; 93..
Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses. Emerging Microbes and Infections. 2019; 8:1642-1657..
Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection. Emerging Microbes and Infections. 2018; 7..
Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform. ACS Nano. 2018; 12:10665-10682..
Quantifying the binding stoichiometry and affinity of histo-blood group antigen oligosaccharides for human noroviruses. Glycobiology. 2018; 28:488-498..
Genetic Analysis of Reemerging GII.P16-GII.2 Noroviruses in 2016-2017 in China. Journal of Infectious Diseases. 2018; 218:133-143..
Human Group C Rotavirus VP8*s Recognize Type A Histo-Blood Group Antigens as Ligands. Journal of Virology. 2018; 92..